E. Riedl

发表

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

J. Dauendorffer, J. Merola, A. Brnabic, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO

S. Zaheri, A. Costanzo, Alan Brnabic, 2024, Dermatology and therapy.